A Look at Alkermes PLC (ALKS) After 4.2% Gain -- GF Value $32.92 vs Price $42.97

gurufocus.com · 2026-10-19

On October 19, 2026, Alkermes PLC (ALKS) shares rose 4.2% to $42.97. The stock has experienced considerable volatility over the past year, trading within a 52-w

TickrTrends take: Alkermes trades at a significant premium to its estimated intrinsic value, with the current market price substantially above the GF Value assessment. For a valuation-focused investor, the gap between these figures underscores TickrTrends' overvalued designation and suggests monitoring whether the stock price moves closer to fundamental value or if the company's underlying business performance justifies the current premium. In the Healthcare sector, this valuation gap warrants observation of upcoming earnings reports and clinical trial results that could either support the higher valuation or create pressure toward the lower estimate.

Read the full story at gurufocus.com →